The association between GLO-1 expression and cancer stage was also assessed, revealing significant stage-dependent differences in BLCA (Stage I = 266, II = 57, III = 123, IV = 81, p = 2.4e−5), LIHC (Stage I = 169, II = 86, III = 85, IV = 5, p = 0.03), and TGCT (Stage I = 104, II = 13, III = 14, p = 0.02) (Figures 1C–E). Here, GLO1 is linked to cancer.